Inpatient Rehabilitation of Hematopoietic Stem Cell Transplant Patients: Managing Challenging Impairments and Medical Fragility
- PMID: 38364030
- PMCID: PMC10878715
- DOI: 10.1097/PHM.0000000000002408
Inpatient Rehabilitation of Hematopoietic Stem Cell Transplant Patients: Managing Challenging Impairments and Medical Fragility
Abstract
Hematopoietic stem cell transplants play an important role in the treatment of cancer, particularly hematologic malignancies. These patients can encounter functional impairments unique to hematopoietic stem cell transplant, including deconditioning, cancer-related fatigue, steroid myopathy, graft versus host disease, and capillary leak syndrome. Medical fragility and increased risk of infection may make rehabilitation challenging on the acute care and postacute care settings. Patients admitted to acute inpatient rehabilitation experience a high rate of transfer to the primary acute service and high rate of mortality after transfer back. Physical medicine and rehabilitation physicians can use a number of strategies to mitigate these patients' risk of medical complications including evidence-based predictive models to assist with postacute rehabilitation triage, physiatry-led consult-based rehabilitation, and oncology hospitalist comanagement on inpatient rehabilitation.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.
Figures
Similar articles
-
Functional Outcomes of Acute Inpatient Rehabilitation in Patients With Chronic Graft-Versus-Host Disease.PM R. 2018 Jun;10(6):567-572. doi: 10.1016/j.pmrj.2017.11.007. Epub 2017 Nov 12. PM R. 2018. PMID: 29141183
-
A Guide to Inpatient Cancer Rehabilitation: Focusing on Patient Selection and Evidence-Based Outcomes.PM R. 2017 Sep;9(9S2):S324-S334. doi: 10.1016/j.pmrj.2017.04.017. PM R. 2017. PMID: 28942907 Free PMC article. Review.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
Inpatient Healthcare Resource Utilization, Costs, and Mortality in Adult Patients with Acute Graft-versus-Host Disease, Including Steroid-Refractory or High-Risk Disease, following Allogeneic Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant. 2020 Mar;26(3):600-605. doi: 10.1016/j.bbmt.2019.10.028. Epub 2019 Nov 1. Biol Blood Marrow Transplant. 2020. PMID: 31678539
-
Rehabilitation in Chronic Graft-Versus-Host Disease.Phys Med Rehabil Clin N Am. 2017 Feb;28(1):143-151. doi: 10.1016/j.pmr.2016.08.009. Phys Med Rehabil Clin N Am. 2017. PMID: 27912993 Review.
References
-
- United States Health Resources & Services Administration https://bloodstemcell.hrsa.gov/data/donation-and-transplantation-statist... Accessed 2/20/2023.
-
- Morishita S, Wakasugi T, Kaida K, Itani Y, Ikegame K, Ogawa H, Domen K. Fatigue, Muscle Oxygen Consumption and Blood Flow to the Skeletal Muscle After Allogeneic Hematopoietic Stem Cell Transplantation. Adv Exp Med Biol. 2018;1072:293–298. - PubMed
-
- Ferrara F, Schiffer CA. Acute myeloid leukaemia in adults. Lancet. Feb 09 2013;381(9865):484–95. - PubMed
-
- Morishita S, Kaida K, Ikegame K, et al. Impaired physiological function and health-related QOL in patients before hematopoietic stem-cell transplantation. Support Care Cancer. Apr 2012;20(4):821–9. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical